The Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis

Comparison of the Global Shoulder Concept (GSC) Method Versus Classic Physical Therapy for Shoulder Tendinitis: a Prospective, Randomized Study

The primary objective of this study is to demonstrate the superiority of the CGE physical therapy protocol versus a standard physical therapy protocol of the shoulder by measuring the following after 1 month of physical therapy: the FI2S score including validated measures of pain, glenohumeral joint range of motion in the three planes, the ability to perform certain everyday activities and the strength of forward elevation measured with a dynamometer.

Study Overview

Detailed Description

Secondary objectives:

  • To study the evolution of passive glenohumeral range of motion
  • To study the evolution of the global range of passive and active motion for each method used
  • To evaluate functional recovery (DASH)
  • To evaluate the impact on quality of life (SF36)
  • To study the difference in visual analog scale scores for pain during physical therapy sessions
  • Compare the two methods/groups after three months.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • CHU de Montpellier - Hôpital Lapeyronie
      • Nîmes Cedex 9, France, 30029
        • CHU de Nimes - Hopital Universitaire Caremeau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • The patient must have given his/her informed and signed consent
  • The patient must be insured or beneficiary of a health insurance plan
  • painful, chronic tendinopathy (more than 3 months) of the rotator cuff, confirmed by MRI

Exclusion Criteria:

  • The patient is pregnant or breastfeeding
  • Any emergency situation
  • Non-mechanical tendinopathies (metabolic, neurological, capsulitis, reflex sympathetic dystrophy) and tendon surgery (tendon surgery and acromioplasty)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: GSC physcial therapy
Patients included in this arm of the study will follow the Global Shoulder Concept physical therapy sequence.
Global Shoulder Concept physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.
ACTIVE_COMPARATOR: Standard
Patients in this arm of the study will follow the standard physical therapy sequence.
Standard physical therapy sequence for shoulder tendonitis. The procedures used in this protocol refer to physical therapy sequences, not to devices or drugs.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
change in FI2S score
Time Frame: 90 days
90 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in visual analog scale for pain
Time Frame: Day 1 versus baseline
Day 1 versus baseline
Change in visual analog scale for pain
Time Frame: Day 5 versus baseline
Day 5 versus baseline
Change in visual analog scale for pain
Time Frame: Day 12 versus baseline
Day 12 versus baseline
Change in visual analog scale for pain
Time Frame: Day 19 versus baseline
Day 19 versus baseline
Change in visual analog scale for pain
Time Frame: Day 26 versus baseline
Day 26 versus baseline
Change in visual analog scale for pain
Time Frame: Day 90 versus baseline
Day 90 versus baseline
Scapulohumeral amplitude gain in 3 main directions
Time Frame: Day 1
Passive and active mobility are evaluated by manual goniometry.
Day 1
Scapulohumeral amplitude gain in 3 main directions
Time Frame: Day 26
Passive and active mobility are evaluated by manual goniometry.
Day 26
Scapulohumeral amplitude gain in 3 main directions
Time Frame: Day 90
Passive and active mobility are evaluated by manual goniometry.
Day 90
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 1
Day 1
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 5
Day 5
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 12
Day 12
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 19
Day 19
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 26
Day 26
Functional gain as measured by the DASH self questionnaire
Time Frame: Day 90
Day 90
FI2S score
Time Frame: Day 1
Day 1
FI2S score
Time Frame: Day 5
Day 5
FI2S score
Time Frame: Day 12
Day 12
FI2S score
Time Frame: Day 19
Day 19
FI2S score
Time Frame: Day 26
Day 26
SF36 self questionnaire
Time Frame: Day 1
Day 1
SF36 self questionnaire
Time Frame: Day 26
Day 26
SF36 self questionnaire
Time Frame: Day 90
Day 90

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Dominique Richard, Centre Hospitalier Universitaire de Nîmes

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (ACTUAL)

May 1, 2016

Study Completion (ACTUAL)

May 1, 2016

Study Registration Dates

First Submitted

February 23, 2012

First Submitted That Met QC Criteria

March 2, 2012

First Posted (ESTIMATE)

March 5, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

June 3, 2016

Last Update Submitted That Met QC Criteria

June 2, 2016

Last Verified

June 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • PHRIP/2011/DR-03
  • 2011-A01168-33 (OTHER: RCB number)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tendinopathy

Clinical Trials on GSC physical therapy

Subscribe